1 asset in Small Intestine Neoplasm
Therapeutic assets addressing Small Intestine Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Nivolumab Small Intestine Neoplasm | Instituto do Cancer do Estado de São Paulo | P2 | CCC (53) |